Panacea Venture — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Domain Therapeuticsdomaintherapeutics.comin𝕏May 2022 · $42M
Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.
BiotechDigital Health
Co-investors3B Future Health FundCTI Life Sciences Fund L.P.adMare BioInnovationsSeventure Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.